HK inno.N Corporation
195940 | KO
Overview
Corporate Details
- ISIN(s):
- KR7195940002
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청주시 흥덕구 오송읍 오송생명2로 239 에이치케이이노엔(주) 오송공장, 청주시
- Website:
- https://www.inno-n.com/eng
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-07-30 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-07-30 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-07-30 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 14.4 KB | ||
| 2025-07-24 00:00 |
Report Publication Announcement
결산실적공시예고
|
Korean | 4.1 KB | ||
| 2025-06-30 00:00 |
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
|
Korean | 10.6 KB | ||
| 2025-06-19 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.3 MB | ||
| 2025-05-07 00:00 |
Regulatory Filings
투자판단관련주요경영사항(임상시험계획승인신청등결정) (IN-B00009의 제3상 임상시험계획 승인)
|
Korean | 10.7 KB | ||
| 2025-04-30 00:00 |
Regulatory Filings
소속부변경
|
Korean | 3.6 KB | ||
| 2025-04-28 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 14.4 KB | ||
| 2025-04-28 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-04-28 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-04-22 00:00 |
Report Publication Announcement
결산실적공시예고
|
Korean | 4.1 KB | ||
| 2025-03-26 00:00 |
AGM Information
정기주주총회결과
|
Korean | 20.7 KB |
Automate Your Workflow. Get a real-time feed of all HK inno.N Corporation filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for HK inno.N Corporation
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HK inno.N Corporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops boron drugs for Boron Neutron Capture Therapy (BNCT), a targeted cancer radiation treatment.
Japan
4888
Japan
4888
Biotech firm commercializing proprietary MIC-1 stem cells through R&D, cultivation, and production.
Poland
SCS
Poland
SCS
Develops and distributes prescription medical cannabis oils in Northern Europe and Australia.
Denmark
STENO
Denmark
STENO
Developing RNA-based medicines for genetic diseases by increasing protein from the healthy gene.
United States of America
STOK
United States of America
STOK
A global CDMO specializing in APIs and RNA therapeutics for the gene therapy market.
South Korea
237690
South Korea
237690
Develops oral small molecule drugs for chronic conditions like metabolic diseases and obesity.
United States of America
GPCR
United States of America
GPCR
Develops advanced in-vitro diagnostic systems for hospitals, clinics, and at-home use.
South Korea
253840
South Korea
253840
Global manufacturer of capsules and contract manufacturing for pharma/nutraceutical industries.
South Korea
008490
South Korea
008490
R&D pharma creating medicines for oncology, psychiatry & neurology, focusing on Japan & the US.
Japan
4506
Japan
4506
Advancing a Phase 3 bispecific antibody for lung cancer and other solid tumors.
United States of America
SMMT
United States of America
SMMT